Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.

MLA

Maini, R. N., et al. “Therapeutic Efficacy of Multiple Intravenous Infusions of Anti-Tumor Necrosis Factor Alpha Monoclonal Antibody Combined with Low-Dose Weekly Methotrexate in Rheumatoid Arthritis.” Arthritis and Rheumatism, vol. 41, no. 9, Sept. 1998, pp. 1552–63. EBSCOhost, https://doi.org/10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W.

APA

Maini, R. N., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Davis, D., Macfarlane, J. D., Antoni, C., Leeb, B., Elliott, M. J., Woody, J. N., Schaible, T. F., & Feldmann, M. (1998). Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis and Rheumatism, 41(9), 1552–1563. https://doi.org/10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W

Chicago

Maini, R N, F C Breedveld, J R Kalden, J S Smolen, D Davis, J D Macfarlane, C Antoni, et al. 1998. “Therapeutic Efficacy of Multiple Intravenous Infusions of Anti-Tumor Necrosis Factor Alpha Monoclonal Antibody Combined with Low-Dose Weekly Methotrexate in Rheumatoid Arthritis.” Arthritis and Rheumatism 41 (9): 1552–63. doi:10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W.